selected publications
-
Journal Article
- Design of FLAT-SUGAR: randomized trial of prandial insulin versus prandial GLP-1 receptor agonist together with basal insulin and metformin for high-risk type 2 diabetes. Diabetes care. 2015
- Author response to lipid-lowering in African Americans in ALLHAT-optimism bias?. Journal of Clinical Hypertension (Greenwich, Conn.). 2013
- Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT). Journal of Clinical Hypertension (Greenwich, Conn.). 2013
- Mortality and morbidity during and after Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: results by sex. Hypertension (Dallas, Tex.. 2013
- Combined intensive blood pressure and glycemic control does not produce an additive benefit on microvascular outcomes in type 2 diabetic patients. Kidney International. 2012
- Long-term effects of intensive glucose lowering on cardiovascular outcomes. New England Journal of Medicine. 2011
- Effects of intensive blood-pressure control in type 2 diabetes mellitus. New England Journal of Medicine. 2010
- ALLHAT findings revisited in the context of subsequent analyses, other trials, and meta-analyses. Archives of Internal Medicine. 2009
- Coronary heart disease in moderately hypercholesterolemic, hypertensive black and non-black patients randomized to pravastatin versus usual care: the antihypertensive and lipid lowering to prevent heart attack trial (ALLHAT-LLT). American Heart Journal. 2009
- Effects of intensive glucose lowering in type 2 diabetes. New England Journal of Medicine. 2008
-
Abstract